{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:14:34Z","timestamp":1785406474751,"version":"3.56.0"},"reference-count":22,"publisher":"Pan African Medical Journal","funder":[{"award":["U01GH002143 - 05"],"award-info":[{"award-number":["U01GH002143 - 05"]}],"id":[{"id":"https:\/\/ror.org\/042twtr12","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PAMJ"],"abstract":"<jats:p>Introduction: Acinetobacter baumannii is a critical priority multidrug-resistant bacterium. Colonization with resistant strains increases the risk of infection and facilitates transmission within healthcare and community settings. However, data on human colonization with drug-resistant A. baumannii remain limited, particularly in low- and middle-income countries. This study investigated and compared the antibiotic susceptibility profiles, resistance patterns, and genetic determinants of gut-colonising A. baumannii isolates from hospital and community settings across urban and rural areas in Kenya.\n\n \n\nMethods: a total of 125 A. baumannii isolates were analysed, comprising 86 community (54 urban, 32 rural) and 39 hospital (21 urban, 18 rural) isolates. Confirmatory identification and antimicrobial susceptibility testing were performed using VITEK\u00ae2 system. Conventional polymerase chain reaction (PCR) was employed to detect resistance genes, including blaCTX-M, blaNDM1, blaOXA-23, blaOXA-48, blaSHV, and blaTEM.\n\n \n\nResults: significant differences in antibiotic resistance were observed between hospital and community isolates (p\u22640.003) across several antibiotics, including ampicillin\/sulbactam, ciprofloxacin, ceftriaxone, cefepime, gentamicin, imipenem, meropenem, and sulfamethoxazole\/trimethoprim. Rural community isolates showed near-universal susceptibility to most antibiotics tested, except for cefazolin and sulfamethoxazole\/trimethoprim. All isolates were resistant to cefazolin but remained susceptible to tigecycline. No statistically significant differences in resistance were observed between urban and rural isolates within hospital or community settings (p &gt; 0.05). Multidrug resistance was exclusively found in hospital isolates, 4 from rural, and 8 from urban, and among these, the blaCTX-M gene was identified in five urban isolates, and blaNDM1 in two rural isolates.\n\n \n\nConclusion: this study highlights the significant impact of the immediate environment (hospital vs. community) on A. baumannii antibiotic resistance profiles and underscores the need for tailored setting-specific interventions to address the evolving challenge of multidrug-resistant A. baumannii.<\/jats:p>","DOI":"10.11604\/pamj.2025.52.111.47901","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:28:41Z","timestamp":1768386521000},"source":"Crossref","is-referenced-by-count":0,"title":["Differences in antibiotic susceptibility among gut-colonizing Acinetobacter baumannii isolated from hospital and community populations in Kenya"],"prefix":"10.11604","author":[{"given":"Robert Maina","family":"Mugoh","sequence":"first","affiliation":[{"name":"University of Nairobi, Department of Medical Microbiology and Immunology, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Mutai","sequence":"additional","affiliation":[{"name":"University of Nairobi Institute of Tropical and Infectious Diseases, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-2784","authenticated-orcid":false,"given":"Victor Moses","family":"Musyoki","sequence":"additional","affiliation":[{"name":"University of Nairobi, Department of Medical Microbiology and Immunology, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-6806","authenticated-orcid":false,"given":"Charchil","family":"Ayodo","sequence":"additional","affiliation":[{"name":"Washington State University Global Health-Kenya, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Oduor","sequence":"additional","affiliation":[{"name":"Washington State University Global Health-Kenya, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moureen","family":"Jepleting","sequence":"additional","affiliation":[{"name":"Washington State University Global Health-Kenya, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ita","sequence":"additional","affiliation":[{"name":"Washington State University Global Health-Kenya, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kiiru","sequence":"additional","affiliation":[{"name":"Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Omulo","sequence":"additional","affiliation":[{"name":"University of Nairobi Institute of Tropical and Infectious Diseases, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"ref0","unstructured":"WHO. Antibiotic resistance. 2020. Accessed on Dec 10, 2023."},{"key":"ref1","unstructured":"WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017. Accessed 10 Dec 2023."},{"key":"ref2","unstructured":"WHO. WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Accessed Dec 10, 2023."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Maragakis LL, Perl TM. Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008 Apr 15;46(8):1254-63. PubMed | Google Scholar","DOI":"10.1086\/529198"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sharma A, Luvsansharav UO, Paul P, Lutgring JD, Call DR, Omulo S et al. Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies. BMC Public Health. 2021 Jul 16;21(1):1412. PubMed | Google Scholar","DOI":"10.1186\/s12889-021-11451-y"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sharma A, Singh A, Dar A, Kaur RJ, Charan J, Iskandar K et al. Menace of antimicrobial resistance in LMICs Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. J Infect Public Health. 2022 Feb;15(2):172-181. PubMed | Google Scholar","DOI":"10.1016\/j.jiph.2021.12.008"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Gootz TD, Marra A. Acinetobacter baumannii: An emerging multidrug-resistant threat. Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. PubMed | Google Scholar","DOI":"10.1586\/14787210.6.3.309"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Smiline ASG, Vijayashree JP, Paramasivam A. Molecular characterization of plasmid-encoded blaTEM, blaSHV and blaCTX-M among extended spectrum \u03b2-lactamases [ESBLs] producing Acinetobacter baumannii. Br J Biomed Sci. 2018 Oct;75(4):200-202. PubMed | Google Scholar","DOI":"10.1080\/09674845.2018.1492207"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bertini A, Poirel L, Bernabeu S, Fortini D, Villa L, Nordmann P et al. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007 Jul;51(7):2324-8. PubMed | Google Scholar","DOI":"10.1128\/AAC.01502-06"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Alyamani EJ, Khiyami MA, Booq RY, Alnafjan BM, Altammami MA, Bahwerth FS. Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2015 Aug 20:14:38. PubMed | Google Scholar","DOI":"10.1186\/s12941-015-0098-9"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ita T, Luvsansharav UO, Smith RM, Mugoh R, Ayodo C, Oduor B et al. Prevalence of colonization with multidrug-resistant bacteria in communities and hospitals in Kenya. Sci Rep. 2022 Dec 24;12(1):22290. PubMed | Google Scholar","DOI":"10.1038\/s41598-022-26842-3"},{"key":"ref11","unstructured":"CLSI. M100 Performance Standards for Antimicrobial Susceptibility Testing. vol. 8. 30th ed. 2020. Accessed Dec 14, 2023."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ranjbar R, Zayeri S, Mirzaie A. Development of multiplex PCR for rapid detection of metallo-\u03b2-lactamase genes in clinical isolates of Acinetobacter baumannii. Iran J Microbiol. 2020 Apr;12(2):107-112. PubMed | Google Scholar","DOI":"10.18502\/ijm.v12i2.2615"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kariuki S, Kering K, Wairimu C, Onsare R, Mbae C. Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now? Infect Drug Resist 2022;15:3589-609. PubMed | Google Scholar","DOI":"10.2147\/IDR.S342753"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Rizk SS, Elwakil WH, Attia AS. Antibiotic-resistant Acinetobacter baumannii in low-income countries (2000-2020): Twenty-one years and still below the radar, is it not there or can they not afford to look for it. Antibiotics (Basel). 2021 Jun 23;10(7):764. PubMed | Google Scholar","DOI":"10.3390\/antibiotics10070764"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Nocera FP, Attili AR, De Martino L. Acinetobacter baumannii: Its Clinical Significance in Human and Veterinary Medicine. Pathogens. 2021 Jan 27;10(2):127. PubMed | Google Scholar","DOI":"10.3390\/pathogens10020127"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Wareth G, Neubauer H, Sprague LD. Acinetobacter baumannii - a neglected pathogen in veterinary and environmental health in Germany. Vet Res Commun. 2019 Feb;43(1):1-6. PubMed | Google Scholar","DOI":"10.1007\/s11259-018-9742-0"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021 Mar 19;10(3):373. PubMed | Google Scholar","DOI":"10.3390\/pathogens10030373"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Huber CA, Sartor AL, McOdimba F, Shah R, Shivachi P, Sidjabat HE et al. Outbreaks of multidrug-resistant Acinetobacter baumannii strains in a Kenyan teaching hospital. J Glob Antimicrob Resist. 2014 Sep;2(3):190-193. PubMed | Google Scholar","DOI":"10.1016\/j.jgar.2014.03.007"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Revathi G, Siu LK, Lu PL, Huang LY. First report of NDM-1-producing Acinetobacter baumannii in East Africa. Int J Infect Dis. 2013 Dec;17(12):e1255-8. PubMed | Google Scholar","DOI":"10.1016\/j.ijid.2013.07.016"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Musyoki VM, Masika MM, Mutai W, Gitau W, Kuria A, Muthini F. Antimicrobial susceptibility pattern of acinetobacter isolates from patients in Kenyatta National Hospital, Nairobi, Kenya. Pan Afr Med J. 2019 Jun 26;33:146. PubMed | Google Scholar","DOI":"10.11604\/pamj.2019.33.146.17220"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Musila L, Kyany\u00b4a C, Maybank R, Stam J, Oundo V, Sang W. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya. PLoS One. 2021 Feb 22;16(2):e0246937. PubMed | Google Scholar","DOI":"10.1371\/journal.pone.0246937"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:28:44Z","timestamp":1768386524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/52\/111\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":22,"URL":"https:\/\/doi.org\/10.11604\/pamj.2025.52.111.47901","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"article-number":"47901"}}